C138H140F3N47O12 — CID 162023253
2-(2,5-dimethyl-4-morpholin-4-ylimidazol-1-yl)-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2,5-dimethyl-4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-(2-methyl-4-morpholin-4-ylimidazol-1-yl)-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-(5-methyl-4-morpholin-4-ylimidazol-1-yl)-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(6-methyl-3-pyridinyl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-[4-[6-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]acetamide (PubChem CID 162023253) has the molecular formula C138H140F3N47O12 and a molecular weight of 2705.95 g/mol. Its IUPAC name is 2-(2,5-dimethyl-4-morpholin-4-ylimidazol-1-yl)-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2,5-dimethyl-4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-(2-methyl-4-morpholin-4-ylimidazol-1-yl)-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-(5-methyl-4-morpholin-4-ylimidazol-1-yl)-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(6-methyl-3-pyridinyl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-[4-[6-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]acetamide.
| Compound Name | 2-(2,5-dimethyl-4-morpholin-4-ylimidazol-1-yl)-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2,5-dimethyl-4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-(2-methyl-4-morpholin-4-ylimidazol-1-yl)-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-(5-methyl-4-morpholin-4-ylimidazol-1-yl)-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(6-methyl-3-pyridinyl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-[4-[6-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]acetamide |
|---|---|
| PubChem CID | 162023253 |
| Molecular Formula | C138H140F3N47O12 |
| Molecular Weight | 2705.95 g/mol |
| Exact Mass | 2704.17 |
| IUPAC Name | 2-(2,5-dimethyl-4-morpholin-4-ylimidazol-1-yl)-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[2,5-dimethyl-4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-(2-methyl-4-morpholin-4-ylimidazol-1-yl)-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-(5-methyl-4-morpholin-4-ylimidazol-1-yl)-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(6-methyl-3-pyridinyl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;2-[4-(oxan-4-yl)imidazol-1-yl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide;N-(5-pyrazin-2-yl-2-pyridinyl)-2-[4-[6-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]acetamide |
| SMILES | Cc1c(N2CCOCC2)ncn1CC(=O)Nc1ccc(-c2cnccn2)cn1.Cc1ccc(-c2cn(CC(=O)Nc3ccc(-c4cnccn4)cn3)cn2)cn1.Cc1nc(C2CCOCC2)c(C)n1CC(=O)Nc1ccc(-c2cnccn2)cn1.Cc1nc(N2CCOCC2)c(C)n1CC(=O)Nc1ccc(-c2cnccn2)cn1.Cc1nc(N2CCOCC2)cn1CC(=O)Nc1ccc(-c2cnccn2)cn1.O=C(Cn1cnc(-c2ccc(C(F)(F)F)nc2)c1)Nc1ccc(-c2cnccn2)cn1.O=C(Cn1cnc(C2CCOCC2)c1)Nc1ccc(-c2cnccn2)cn1 |
| InChI | InChI=1S/C21H24N6O2.C20H14F3N7O.C20H23N7O2.C20H17N7O.2C19H21N7O2.C19H20N6O2/c1-14-21(16-5-9-29-10-6-16)25-15(2)27(14)13-20(28)26-19-4-3-17(11-24-19)18-12-22-7-8-23-18;21-20(22,23)17-3-1-14(7-26-17)16-10-30(12-28-16)11-19(31)29-18-4-2-13(8-27-18)15-9-24-5-6-25-15;1-14-20(26-7-9-29-10-8-26)24-15(2)27(14)13-19(28)25-18-4-3-16(11-23-18)17-12-21-5-6-22-17;1-14-2-3-16(8-23-14)18-11-27(13-25-18)12-20(28)26-19-5-4-15(9-24-19)17-10-21-6-7-22-17;1-14-19(25-6-8-28-9-7-25)23-13-26(14)12-18(27)24-17-3-2-15(10-22-17)16-11-20-4-5-21-16;1-14-23-18(25-6-8-28-9-7-25)12-26(14)13-19(27)24-17-3-2-15(10-22-17)16-11-20-4-5-21-16;26-19(12-25-11-17(23-13-25)14-3-7-27-8-4-14)24-18-2-1-15(9-22-18)16-10-20-5-6-21-16/h3-4,7-8,11-12,16H,5-6,9-10,13H2,1-2H3,(H,24,26,28);1-10,12H,11H2,(H,27,29,31);3-6,11-12H,7-10,13H2,1-2H3,(H,23,25,28);2-11,13H,12H2,1H3,(H,24,26,28);2-5,10-11,13H,6-9,12H2,1H3,(H,22,24,27);2-5,10-12H,6-9,13H2,1H3,(H,22,24,27);1-2,5-6,9-11,13-14H,3-4,7-8,12H2,(H,22,24,26) |
| InChIKey | YVAHJOBCMARRMS-UHFFFAOYSA-N |
| XLogP | 16.22 |
| TPSA | 680.78 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 52 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 200 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2705.95 |
| LogP ≤ 5 | 16.22 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 52 |